BTG Competitors and Similar CompaniesClear all
BTG's competitors and similar companies include Avid Bioservices, Skyepharma and Societal CDMO.
 Avid Bioservices Avid Bioservices, formerly Peregrine Pharmaceuticals, is a biopharmaceutical company. |  Societal CDMO Recro Gainesville (also known as Recro Pharma) is a clinical-stage specialty pharmaceutical company developing non-opioid therapeutics for the treatment of acute post-operative pain. | |||
Founding Date | Founding Date 1948 | Founding Date 1981 | Founding Date 1996 | Founding Date 2006 |
Type | Type Subsidiary | Type Public | Type Subsidiary | Type Public |
Tags | ||||
Locations | Locations Tustin, US HQ | Locations Saint-Quentin-Fallavier, FR HQ | Locations Gainesville, US HQ Gainesville, US San Diego, US | |
Employees | Employees 640 | Employees 21114% increase | Employees 2081% increase | Employees 21316% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 672.4 m | Valuation ($) N/A | Valuation ($) 116.1 m |
Financial | ||||
Revenue (est.) | Revenue (est.) £731.3m (FY, 2019) | Revenue (est.) $139.9m (FY, 2024) | Revenue (est.) £95.9m (FY, 2015) | Revenue (est.) $94.6m (FY, 2023) |
Cost of goods | Cost of goods £221m (FY, 2019) | Cost of goods $132.6m (FY, 2024) | Cost of goods £43.1m (FY, 2015) | Cost of goods $76.5m (FY, 2023) |
Gross profit | Gross profit £510.3m (FY, 2019) | Gross profit $7.3m (FY, 2024) | Gross profit £52.8m (FY, 2015) | Gross profit N/A |
Net income | Net income £88.3m (FY, 2019) | Net income ($140.8m) (FY, 2024) | Net income N/A | Net income ($13.3m) (FY, 2023) |
For sources of this data, please see the company profile
View Company Profiles
Avid Bioservices
HQ
Tustin, US
Employees
211↑ 14% increase
Avid Bioservices, formerly Peregrine Pharmaceuticals, is a biopharmaceutical company.
View company
Skyepharma
HQ
Saint-Quentin-Fallavier, FR
Skyepharma is a drug delivery company developing oral and inhalation products.
View companySocietal CDMO
HQ
Gainesville, US
Employees
213↓ 16% decrease
Recro Gainesville (also known as Recro Pharma) is a clinical-stage specialty pharmaceutical company developing non-opioid therapeutics for the treatment of acute post-operative pain.
View company